Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Lesluyes

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|May 18, 2026
Scalable subclonal reconstruction of cancer cells in DNA sequencing data using a penalized likelihood modelYujie Jiang, Matthew D Montierth, Yu Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine LeiomyosarcomasSabrina Croce, Tom Lesluyes, Carine Valle, et al.
Life Science Alliance|November 21, 2018
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activityCaroline Giessner, Virginie Millet, Konrad J Mostert, et al.
Genes, Chromosomes & Cancer|October 24, 2018
GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangementSabrina Croce, Tom Lesluyes, Lucile Delespaul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
The American Journal of Surgical Pathology|March 5, 2019
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular SpectrumFrançois Le Loarer, Sophie Laffont, Tom Lesluyes, et al.
Genome Medicine|August 30, 2022
A genetic model for central chondrosarcoma evolution correlates with patient outcomeWilliam Cross, Iben Lyskjær, Tom Lesluyes, et al.
Cell Cycle (Georgetown, Tex.)|November 25, 2017
Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elementsStéphanie Durrieu-Gaillard, Hélène Dumay-Odelot, Galina Boldina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumorsSabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, et al.
British Journal of Cancer|October 13, 2017
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcomaCarmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|May 18, 2026
Scalable subclonal reconstruction of cancer cells in DNA sequencing data using a penalized likelihood modelYujie Jiang, Matthew D Montierth, Yu Ding, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
The Nanocind Signature Is an Independent Prognosticator of Recurrence and Death in Uterine LeiomyosarcomasSabrina Croce, Tom Lesluyes, Carine Valle, et al.
Life Science Alliance|November 21, 2018
Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activityCaroline Giessner, Virginie Millet, Konrad J Mostert, et al.
Genes, Chromosomes & Cancer|October 24, 2018
GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangementSabrina Croce, Tom Lesluyes, Lucile Delespaul, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2019
Genomic and transcriptomic comparison of post-radiation versus sporadic sarcomasTom Lesluyes, Jessica Baud, Gaëlle Pérot, et al.
The American Journal of Surgical Pathology|March 5, 2019
Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular SpectrumFrançois Le Loarer, Sophie Laffont, Tom Lesluyes, et al.
Genome Medicine|August 30, 2022
A genetic model for central chondrosarcoma evolution correlates with patient outcomeWilliam Cross, Iben Lyskjær, Tom Lesluyes, et al.
Cell Cycle (Georgetown, Tex.)|November 25, 2017
Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elementsStéphanie Durrieu-Gaillard, Hélène Dumay-Odelot, Galina Boldina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumorsSabrina Croce, Agnès Ducoulombier, Agnès Ribeiro, et al.
British Journal of Cancer|October 13, 2017
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcomaCarmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, et al.
Pageof 5